W. Nathaniel Brennen

Author

Also Known As

Brennen, W. Nathaniel, W Nathaniel Brennen, W. N. Brennen, W. Nathaniel Brennen, W.N. Brennen, WN Brennen, William N. Brennen, William Nathaniel Brennen, W Nathaniel Brennen

151

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Medicine University of Washington Fred Hutch Cancer Center

About

W. Nathaniel Brennen is an author at Johns Hopkins University specializing in medicine, tumor microenvironment, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	537
2	Cell Biology	6	6	321
3	Engineering	2	2	94
4	Biomedical Engineering	2	2	94
5	Health Sciences	1	1	85

W. Nathaniel Brennen

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy Samuel R. Denmeade, Annastasiah Mhaka, Dina Rosen, Science Translational Medicine	2012	215
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth Jianqing Lin, Michael C. Haffner, Yonggang Zhang, The Prostate	2010	192
Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug W. Nathaniel Brennen, David Rosen, H. Wang, JNCI Journal of the National Cancer Institute	2012	183
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin Aaron M. LeBeau, W. Nathaniel Brennen, Saurabh Aggarwal, Molecular Cancer Therapeutics	2009	152
A Phase I Study to Assess the Safety and Cancer-Homing Ability of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Men with Localized Prostate Cancer Michael T. Schweizer, Hao Wang, Trinity J. Bivalacqua, Stem Cells Translational Medicine	2019	122
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment John T. Isaacs, Lizamma Antony, Susan L. Dalrymple, Cancer Research Colon Tumor XenograftsChemoprevention StrategyImmunologyHistone Deacetylase Hdac4Cell Death	2012	110
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors Yezi Zhu, Susan L. Dalrymple, Ilsa M. Coleman, Oncogene Urology2Nd-generation Androgen ReceptorMedicineHormonal ReceptorProstatic Disease	2020	99
Fibroblast Activation Protein Peptide Substrates Identified from Human Collagen I Derived Gelatin Cleavage Sites Saurabh Aggarwal, W. Nathaniel Brennen, Thomas P. Kole, Biochemistry	2007	89
Quantification of Mesenchymal Stem Cells (MSCs) at Sites of Human Prostate Cancer W. Nathaniel Brennen, Shuangling Chen, Samuel R. Denmeade, Oncotarget Innate TropismImmunologyBiological MicroenvironmentsTumor BiologyHuman Prostate Cancer	2012	85
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models Nora M. Navone, Wytske M. van Weerden, Robert L. Vessella, The Prostate	2018	85

Page 1